Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents : Implications in peptide delivery to the colon
- Author
- TOZAKI, H1 ; EMI, Y1 ; HORISAKA, E1 ; FUJITA, T1 ; YAMAMOTO, A1 ; MURANISHI, S1
[1] Department of Biopharmaceutics, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607, Japan - Source
Journal of pharmacy and pharmacology. 1997, Vol 49, Num 2, pp 164-168 ; ref : 16 ref
- CODEN
- JPPMAB
- ISSN
- 0022-3573
- Scientific domain
- Pharmacology drugs
- Publisher
- Pharmaceutical Press, Wallingford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Animal Association médicamenteuse Caecum Calcitonine Dégradation enzymatique Hormone protéine In vitro Inhibiteur enzyme Insuline Médicament Métabolisme Peptidases Peptide CGRP Peptide Rat Enzyme Hydrolases Mammalia Rodentia Vertebrata
- Keyword (en)
- Animal Drug combination Cecum Calcitonin Enzymatic digestion Protein hormone In vitro Enzyme inhibitor Insulin Drug Metabolism Peptidases Calcitonine gene related peptide Peptides Rat Enzyme Hydrolases Mammalia Rodentia Vertebrata
- Keyword (es)
- Animal Asociación medicamentosa Caecum Calcitonina Degradación enzimática Hormona proteina In vitro Inhibidor enzima Insulina Medicamento Metabolismo Peptidases Péptida CGRP Péptido Rata Enzima Hydrolases Mammalia Rodentia Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02O Hormones. Endocrine system
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2576643
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.2042-7158.1997.tb06773.x 
https://dx.doi.org/10.1111/j.2042-7158.1997.tb06773.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.2042-7158.1997.tb06773.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:160:\"Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents : Implications in peptide delivery to the colon\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of pharmacy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. pharm. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"164\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3573\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TOZAKI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:6:\"EMI, Y\";i:1;s:11:\"HORISAKA, E\";i:2;s:9:\"FUJITA, T\";i:3;s:11:\"YAMAMOTO, A\";i:4;s:12:\"MURANISHI, S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPPMAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:160:\"Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents : Implications in peptide delivery to the colon\";s:8:\"\u0000*\u0000place\";s:11:\"Wallingford\";s:6:\"\u0000*\u0000pub\";s:20:\"Pharmaceutical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.2042-7158.1997.tb06773.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:160:\"Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents : Implications in peptide delivery to the colon\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of pharmacy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. pharm. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"164\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3573\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TOZAKI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:6:\"EMI, Y\";i:1;s:11:\"HORISAKA, E\";i:2;s:9:\"FUJITA, T\";i:3;s:11:\"YAMAMOTO, A\";i:4;s:12:\"MURANISHI, S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPPMAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:160:\"Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents : Implications in peptide delivery to the colon\";s:8:\"\u0000*\u0000place\";s:11:\"Wallingford\";s:6:\"\u0000*\u0000pub\";s:20:\"Pharmaceutical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.2042-7158.1997.tb06773.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.2042-7158.1997.tb06773.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:160:\"Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents : Implications in peptide delivery to the colon\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of pharmacy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. pharm. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"164\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3573\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TOZAKI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:6:\"EMI, Y\";i:1;s:11:\"HORISAKA, E\";i:2;s:9:\"FUJITA, T\";i:3;s:11:\"YAMAMOTO, A\";i:4;s:12:\"MURANISHI, S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPPMAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:160:\"Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents : Implications in peptide delivery to the colon\";s:8:\"\u0000*\u0000place\";s:11:\"Wallingford\";s:6:\"\u0000*\u0000pub\";s:20:\"Pharmaceutical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.2042-7158.1997.tb06773.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:160:\"Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents : Implications in peptide delivery to the colon\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of pharmacy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. pharm. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"164\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3573\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TOZAKI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:6:\"EMI, Y\";i:1;s:11:\"HORISAKA, E\";i:2;s:9:\"FUJITA, T\";i:3;s:11:\"YAMAMOTO, A\";i:4;s:12:\"MURANISHI, S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPPMAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:160:\"Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents : Implications in peptide delivery to the colon\";s:8:\"\u0000*\u0000place\";s:11:\"Wallingford\";s:6:\"\u0000*\u0000pub\";s:20:\"Pharmaceutical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
